Aberrant expression of CD14 in breast tumor cells is associated with poor outcome
Hiroyuki Katayama, Rongzhang Dou, Ricardo A. Léon-Letelier…·Samir Hanash
This study identifies aberrant CD14 expression in breast tumor cells as a marker of poor clinical outcomes and aggressive disease.